Citation Impact
Citing Papers
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
2009 Standout
Identification and Testing of a Gene Expression Signature of Invasive Carcinoma Cells within Primary Mammary Tumors
2004
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
2010
Identification of Markers of Taxane Sensitivity Using Proteomic and Genomic Analyses of Breast Tumors from Patients Receiving Neoadjuvant Paclitaxel and Radiation
2010
A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
2012
Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival
2005
Tissue-Wide Expression Profiling Using cDNA Subtraction and Microarrays to Identify Tumor-Specific Genes
2004
From latent disseminated cells to overt metastasis: Genetic analysis of systemic breast cancer progression
2003
Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
2006
Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis
2005
The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer
2008
An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival
2005
Lung metastasis genes couple breast tumor size and metastatic spread
2007
Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less
2002
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients
2005
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
2006
A Gene Expression Signature that Can Predict the Recurrence of Tamoxifen-Treated Primary Breast Cancer
2008
Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009
2009
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
2008
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera
2004
Identification of molecular apocrine breast tumours by microarray analysis
2005
Concordance among Gene-Expression–Based Predictors for Breast Cancer
2006
GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
2009 Standout
Comprehensive molecular portraits of human breast tumours
2012 StandoutNature
Biologic markers determine both the risk and the timing of recurrence in breast cancer
2011
A Basal Epithelial Phenotype Is More Frequent in Interval Breast Cancers Compared with Screen Detected Tumors
2005
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
2003
Breast cancer stem cells: implications for therapy of breast cancer
2008
Data driven derivation of cutoffs from a pool of 3,030 Affymetrix arrays to stratify distinct clinical types of breast cancer
2009
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
2008
Hallmarks of Cancer: The Next Generation
2011 Standout
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
2004 Standout
Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer
2003
Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m 6 A-demethylation of NANOG mRNA
2016 StandoutNobel
The relationship between prognostic and predictive factors in the management of breast cancer
1998
High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses
2005
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
2009
Genomic profiling of breast tumours in relation to BRCAabnormalities and phenotypes
2009
Predictors of Resistance to Preoperative Trastuzumab and Vinorelbine for HER2-Positive Early Breast Cancer
2007
Triple-Negative Breast Cancer
2010 Standout
Breast Tumor Kinase (Brk/PTK6) Is a Mediator of Hypoxia-Associated Breast Cancer Progression
2013
Hallmarks of 'BRCAness' in sporadic cancers
2004
MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer
2003
Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis
2014 Standout
Two-Color, Cytokeratin-Labeled DNA Flow Cytometric Analysis of 332 Breast Cancers
2001
The molecular underpinning of lobular histological growth pattern: a genome‐wide transcriptomic analysis of invasive lobular carcinomas and grade‐ and molecular subtype‐matched invasive ductal carcinomas of no special type
2009
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade
2009
HER2 and Responsiveness of Breast Cancer to Adjuvant Chemotherapy
2006
Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis
2007
Origins of breast cancer subtypes and therapeutic implications
2007
Comparison of the prognostic and predictive utilities of the 21-gene Recurrence Score assay and Adjuvant! for women with node-negative, ER-positive breast cancer: results from NSABP B-14 and NSABP B-20
2011
Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown
2018 StandoutNobel
Innate and adaptive immune cells in the tumor microenvironment
2013 Standout
A Core MYC Gene Expression Signature Is Prominent in Basal-Like Breast Cancer but Only Partially Overlaps the Core Serum Response
2009
X chromosomal abnormalities in basal-like human breast cancer
2006
Migrastatin analogues target fascin to block tumour metastasis
2010 Nature
Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series
2007
An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer
2007
BRCA1 : mechanisms of inactivation and implications for management of patients
2002
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
2005 Standout
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts
2005
Profiling the Breast Cancer Proteome — The New Tool of the Future?
2006
Epithelial-Mesenchymal Transitions
2004 Standout
Stromal gene expression predicts clinical outcome in breast cancer
2008
A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers
2006
Tumor Metastasis: Molecular Insights and Evolving Paradigms
2011 Standout
Mutation of GATA3 in human breast tumors
2004
Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage
2003 StandoutNatureNobel
Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis
2007
Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer
2009
Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures
2008
A multigenic program mediating breast cancer metastasis to bone
2003 Standout
Gene expression patterns associated with p53 status in breast cancer
2006
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
2010 Standout
Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer
2010
Histological and molecular types of breast cancer: is there a unifying taxonomy?
2009
WNT pathway and mammary carcinogenesis: Loss of expression of candidate tumor suppressor gene SFRP1 in most invasive carcinomas except of the medullary type
2001
Rules of evidence for cancer molecular-marker discovery and validation
2004
Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function
2004 StandoutNobel
Epithelial–mesenchymal transitions in tumour progression
2002 Standout
Suppression of lung adenocarcinoma progression by Nkx2-1
2011 Nature
How basal are triple‐negative breast cancers?
2008
REVIGO Summarizes and Visualizes Long Lists of Gene Ontology Terms
2011 Standout
CD44+/CD24-breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis
2006
A molecular signature of metastasis in primary solid tumors
2002 Standout
Insight into the heterogeneity of breast cancer through next-generation sequencing
2011
Validation and Clinical Utility of a 70-Gene Prognostic Signature for Women With Node-Negative Breast Cancer
2006
Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer
2003
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status
2010
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer
2006
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
2005
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
2007
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Gene expression predictors in breast cancer: Current status, limitations and perspectives
2008
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
2010 Standout
Identifying Site-specific Metastasis Genes and Functions
2005
A Mechanism of Cyclin D1 Action Encoded in the Patterns of Gene Expression in Human Cancer
2003
Emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis
2005
Measurement of Gene Expression in Archival Paraffin-Embedded Tissues
2004
Biomarkers in Cancer Staging, Prognosis and Treatment Selection
2005
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1
2002
Comparative biology of mouse versus human cells: modelling human cancer in mice
2003
L2L: a simple tool for discovering the hidden significance in microarray expression data
2005
Current and emerging concepts in tumour metastasis
2010
GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer Model
2008
Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data
2003
Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors
2005
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
2011 Standout
The predictive value of the 70-gene signature for adjuvant chemotherapy in early breast cancer
2010
Gene-Expression Signatures in Breast Cancer
2009
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
2004 Standout
BRCA1 functions as a breast stem cell regulator
2004
GOBO: Gene Expression-Based Outcome for Breast Cancer Online
2011
Molecular Basis of Metastasis
2008
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005
2005
ClustVis: a web tool for visualizing clustering of multivariate data using Principal Component Analysis and heatmap
2015 Standout
BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells
2010
MicroRNA expression profiles classify human cancers
2005 StandoutNatureNobel
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
2004
A stromal gene signature associated with inflammatory breast cancer
2007
Prognostic molecular markers in early breast cancer
2004
Gene expression predictors of breast cancer outcomes
2003
ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome
2007 Standout
Systemic Spread Is an Early Step in Breast Cancer
2008
BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles
2005
Adjuvant therapies for special types of breast cancer
2011
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
2010 Standout
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds
2004
Cancer-related inflammation
2008 StandoutNature
Lysosome-targeting chimaeras for degradation of extracellular proteins
2020 StandoutNatureNobel
Expression of Interleukin 11 and Its Receptor and Their Prognostic Value in Human Breast Cancer
2006
The fundamental role of epigenetic events in cancer
2002 Standout
Molecular portraits and the family tree of cancer
2002
Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
2010
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study
2006 Standout
Tumor Markers in Breast Cancer – European Group on Tumor Markers Recommendations
2005
Deconstructing the molecular portraits of breast cancer
2010
Selection of Bone Metastasis Seeds by Mesenchymal Signals in the Primary Tumor Stroma
2013
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Metastatic Potential
2003
The Prognostic Role of a Gene Signature from Tumorigenic Breast-Cancer Cells
2007
An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen
2006
Practical Approach to Triple-Negative Breast Cancer
2017
Gene expression profiles of primary breast tumors maintained in distant metastases
2003
Gene Expression Profiling of Breast Cancer: A New Tumor Marker
2005
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
2003 Standout
Trastuzumab in the management of early and advanced stage breast cancer.
2007
Gene Expression Profiles and Molecular Markers To Predict Recurrence of Dukes' B Colon Cancer
2004
Short-term significance of DNA ploidy and cell proliferation in breast carcinoma: a multivariate analysis of prognostic markers in a series of 308 patients.
1999
Selective Estrogen Receptor Modulators
2004
Repeated observation of breast tumor subtypes in independent gene expression data sets
2003 Standout
Breast Cancer Subtypes and the Risk of Local and Regional Relapse
2010
Immune targeting in breast cancer.
2015
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer
2005
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Agreement in Breast Cancer Classification between Microarray and Quantitative Reverse Transcription PCR from Fresh-Frozen and Formalin-Fixed, Paraffin-Embedded Tissues
2007
Proteomics and the Analysis of Proteomic Data: An Overview of Current Protein‐Profiling Technologies
2005
Which Cyclin E Prevails as Prognostic Marker for Breast Cancer? Results from a Retrospective Study Involving 635 Lymph Node–Negative Breast Cancer Patients
2006
Breast Cancer Subtypes and Response to Docetaxel in Node-Positive Breast Cancer: Use of an Immunohistochemical Definition in the BCIRG 001 Trial
2009
A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen
2006
Associations between gene expressions in breast cancer and patient survival
2002
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
2010
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression
2012 StandoutNobel
Molecular signature associated with bone marrow micrometastasis in human breast cancer.
2003
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
2006
Gene expression profiles of human breast cancer progression
2003
Immunotherapy: Bewitched, Bothered, and Bewildered No More
2004 StandoutScienceNobel
The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1 -Related Breast Cancer
2004
Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis
2006 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
2006
Chemotherapy triggers HIF-1–dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
2015 StandoutNobel
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
2002
Hierarchical Clustering Analysis of Tissue Microarray Immunostaining Data Identifies Prognostically Significant Groups of Breast Carcinoma
2004
Definition of Clinically Distinct Molecular Subtypes in Estrogen Receptor–Positive Breast Carcinomas Through Genomic Grade
2007
Molecular Classification and Molecular Forecasting of Breast Cancer: Ready for Clinical Application?
2005
Selective Inhibition of BRCA2-Deficient Mammary Tumor Cell Growth by AZD2281 and Cisplatin
2008
The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer
2006
Chemical Glycoproteomics
2016 StandoutNobel
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
2006 StandoutScience
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer
2002
Works of Hans Peterse being referenced
Gene expression profiling predicts clinical outcome of breast cancer
2002 StandoutNature
Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer
2001
Prognostic implications of different cell cycle analysis models of flow cytometric DNA histograms of 1,301 breast cancer patients: Results from the multicenter morphometric mammary carcinoma project (MMMCP)
1997
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for High-Risk Breast Cancer
2003
Local recurrence after breast conservation therapy for early stage breast carcinoma
1999
Continuing Risk of Ipsilateral Breast Relapse After Breast-Conserving Therapy at Long-Term Follow-up
2008
Efficacy of MRI and Mammography for Breast-Cancer Screening in Women with a Familial or Genetic Predisposition
2004
Further evaluation of the prognostic value of morphometric and flow cytometric parameters in breast‐cancer patients with long follow‐up
1990
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
2007
Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
1997